APA (7th ed.) Citation

Gulley, J. L., Patel, M. R., Lee, K., Dirix, L., Ruisi, M., Infante, J. R., . . . Pennock, G. Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Gulley, James L., et al. Avelumab as Second-line Therapy for Metastatic, Platinum-treated Urothelial Carcinoma in the Phase Ib JAVELIN Solid Tumor Study: 2-year Updated Efficacy and Safety Analysis. BMJ Publishing Group.

MLA (9th ed.) Citation

Gulley, James L., et al. Avelumab as Second-line Therapy for Metastatic, Platinum-treated Urothelial Carcinoma in the Phase Ib JAVELIN Solid Tumor Study: 2-year Updated Efficacy and Safety Analysis. BMJ Publishing Group.